Bharti Airtel Deploys Additional 28.2 MHz Spectrum In Uttar Pradesh
Share price of Bharti Airtel edged lower by more than one per cent on Tuesday, June 29, a day after the telecom operator announced that it added an additional 28.2Â MHz spectrum in Uttar Pradesh, in order to boost the network capacity for offering high-speed data services. On Tuesday, Bharti Airtel opened on the BSE at Rs 531.20, inching to an intra day high of Rs 532.25 and an intra day low of Rs 524, throughout the trading session today.Â
According to news agency PTI, the telecom operator said that it ready for 5G technology. With the latest spectrum addition, Bharti Airtel claims that it now has the largest spectrum bank of 72.2 MHz in the country's most populated state. It added that it has the largest network bank in Uttar Pradesh (East) and is well-positioned to cater to the growing demand for data services.
The deployment of the additional spectrum will allow a better availability of network and data services, along with improved coverage in homes, building, and offices, according to Airtel.
On the NSE, Bharti Airtel opened at Rs 531.25, registering an intra day high of Rs 532.25 and an intra day low of Rs 524, during the trading session. On the NSE, Bharti Airtel settled 1.13 per cent lower at Rs 525.20 apiece today.
Shares of Bharti Airtel settled 0.97 per cent lower at Rs 526 apiece on the BSE.
Meanwhile, it was recently reported that Bharti Airtel and Tata Group entered into a strategic partnership for implementing 5G networks solutions for the country. The telecom operator will pilot and deploy the indigenous solution as part of the 5G rollout plans and will begin the pilot in January 2022 according to formulated guidelines by the central government.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.